Regencell Bioscience’s investigational liquid-formula RGC-COV19TM shows effectiveness through its enrolled patients
• 36 out of 37 COVID-19 patients treated in the trial, representing approximately 97.3% of the patients, reported they had all symptoms eliminated within the 6-day treatment period save for loss or reduced sense of taste and smell (“Sensory Dysfunction”) and occasional cough. The highest number of different symptoms reported for any one individual was 14.
Mobil 1™ and Porsche celebrate 25th anniversary milestone with extension deal
Delivering 25 years of collaboration, exceptional performance, protection in extreme conditions and outstanding driving experiences, Mobil 1 and Porsche will remain long-term partners.
IDX Monitors SUPR Share Transaction Activity
The Indonesian Stock Exchange (IDX) is currently monitoring the price developments and stock transaction activities of PT Solusi Tunas Pratama Tbk (SUPR).